This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked RPS15 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RPS15 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~17 kDa | |
| Gel | 15% (standard starting point) | |
| Positive control | Breast (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Acetylated + Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A06538 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | SK-OVCAR3 (40ug), HEK293T (40ug), A549 (40ug), AML-12 (40ug), PC12 (40ug) (catalog A06538) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A06538; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
RPS15 is predicted at 17 kDa; its N-terminal acetylation is documented, but a migration effect and an empirical band size are not established.
| Single band near 17 kDa | consistent with the predicted size of RPS15 |
| Band near 17 kDa in whole-cell lysate | consistent with its cytoplasmic location |
| Faint band near 17 kDa | possible RPS15 signal; confirm with an identity control |
| No band near 17 kDa | RPS15 is not detected under these conditions |
| Predicted molecular mass | sets a 17 kDa reference for the unmodified protein |
| 145-residue sequence | underlies the predicted molecular mass |
| N-acetylalanine at residue 2 | is documented, but no visible migration effect is established |
| Small ribosomal subunit association | does not establish a different denaturing gel band size |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | RPS15 is not detected despite its cytoplasmic location | check lysate loading and antibody performance with a positive-control lysate |
| Band higher than expected | the identity of the higher band is unestablished | compare with a molecular-weight marker and confirm specificity by RPS15 depletion |
| Band lower than expected | the identity of the lower band is unestablished | check sample integrity and confirm specificity by RPS15 depletion |
| Multiple bands | a single isoform is listed, so the additional bands have no established RPS15 explanation | use RPS15 depletion to identify the specific band |
| Weak or no signal | insufficient detectable RPS15 or ineffective detection | check loading and detection with a positive-control lysate |
| Fragments below expected size | sample degradation is possible; no cleavage feature is listed | prepare fresh lysate with protease inhibitors and compare with an RPS15 identity control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | GLUC cells - cytoplasm/membrane | High | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | High | Protein (IHC) | HPA → |
| Colon | endocrine cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Not detected | Protein (IHC) | HPA → |
| Gallbladder | glandular cells | Low | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for RPS15, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A06538 is a polyclonal anti-RPS15 antibody listed as reactive with human, mouse, and rat. Its WB image shows 40 µg whole-cell lysates from SK-OVCAR3, HEK293T, A549, AML-12, and PC12 at 1:500. No further validation is supplied.
Which to pick: A06538 is the only listed antibody and has a WB image. Choose it as a starting point for the named sample contexts; confirm performance with your own samples and conditions.